Jack Campbell, MD
Urology · Columbia, MONPI 1649633736
Payments from drug & device makers
What this record shows
This record is dominated by grants: $50,000 of the $53,690 with a category attached, or 93.1%. Boston Scientific accounts for 97.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $50,063 and has fallen 97.8% since, to $1,112 in 2025. Among urology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $715.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$52K
- Coloplast$338
- Astellas Pharma US Inc$239
- Calyxo, Inc.$145
- Endo USA, Inc.$139
- Medtronic$115
- plus $441 from 11 others
What the payments were for
- Grants$50,00093%
- Travel & lodging$4421%
- Food & beverage$3,0836%
- Education$1650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 43 | $52,274 |
| Coloplast | 6 | $338 |
| Astellas Pharma US Inc | 5 | $239 |
| Calyxo, Inc. | 1 | $145 |
| Endo USA, Inc. | 3 | $139 |
| Medtronic | 3 | $115 |
| Merck | 2 | $108 |
| Olympus America Inc. | 2 | $68 |
| Axonics, Inc. | 1 | $58 |
| Procept Biorobotics Corporation | 1 | $36 |
| Johnson & Johnson(2 entities) | 2 | $32 |
| Ferring Pharmaceuticals Inc. | 1 | $30 |
| Laborie Medical Technologies Corp. | 1 | $27 |
| Edwards Lifesciences | 1 | $24 |
| Vertex | 1 | $24 |
| Convatec Inc. | 1 | $18 |
| 180 Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$50,134
- AMS 700 CXR RTE KIT$686
- LithoVue$285
- CVAC Aspiration System$145
- AMS 800 Artificial Urinary Sphincter$144
- AMS$123
- TITAN$121
- AMS 700$108
How this compares
$53,690 in reported general payments places this provider in the 95th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 23 | $11,851 |
| Trospium Chloride ErTrospium Chloride | 14 | $2,309 |
| Tamsulosin Hcl | 148 | $1,466 |
| Sodium Chloride0.9 % Sodium Chloride | 11 | $696 |
| Nystatin | 33 | $682 |
| Finasteride | 52 | $572 |
| Testosterone Cypionate | 14 | $554 |
| Trospium Chloride | 13 | $543 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $441 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 16 | $400 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 32 | $174 |
| Doxycycline Hyclate | 14 | $167 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $155 |
| Oxycodone Hcl | 34 | $132 |
| Ciprofloxacin Hcl | 15 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $239 | $11,85123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 250 urology providers in Missouri.
Other urology in Columbia
- Julie RileyColumbia$10K
- Travis BullockSaint Louis$201K
- Michael JohnsonSaint Louis$160K
- Samuel KuykendallKansas City$141K
- Gerald ParkNorth Kansas City$136K
- Gurdarshan SandhuSaint Louis$101K
- Etai GoldenbergSt. Louis$95K
- Gregory McLennanSaint Louis$89K
- Majdee IslamSaint Peters$64K
- Gerald AndrioleSaint Louis$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.